These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7998786)
1. Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Benedikz J; Magnússon H; Guthmundsson G Ann Neurol; 1994 Dec; 36 Suppl 2():S175-9. PubMed ID: 7998786 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological aspects. Poser CM; Hibberd PL; Benedikz J; Gudmundsson G Neuroepidemiology; 1988; 7(4):168-80. PubMed ID: 3194042 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis in the Faroe Islands: an epitome. Kurtzke JF; Heltberg A J Clin Epidemiol; 2001 Jan; 54(1):1-22. PubMed ID: 11165464 [TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Kurtzke JF; Gudmundsson KR; Bergmann S Neurology; 1982 Feb; 32(2):143-50. PubMed ID: 6976526 [TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis incidence in the Faroe Islands 1986-2007. Joensen P Acta Neurol Scand; 2010 May; 121(5):348-53. PubMed ID: 20015109 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the 'epidemic' of multiple sclerosis in the Faroe Islands. II. Biostatistical aspects. Poser CM; Hibberd PL Neuroepidemiology; 1988; 7(4):181-9. PubMed ID: 3194043 [TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis in the Faroe Islands. 5. The occurrence of the fourth epidemic as validation of transmission. Kurtzke JF; Hyllested K; Heltberg A; Olsen A Acta Neurol Scand; 1993 Sep; 88(3):161-73. PubMed ID: 8256551 [TBL] [Abstract][Full Text] [Related]
8. Validity of the epidemics of multiple sclerosis in the Faroe Islands. Kurtzke JF; Hyllested K Neuroepidemiology; 1988; 7(4):190-227. PubMed ID: 3264056 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of multiple sclerosis: the Iceland model. Onset-adjusted prevalence rate and other methodological considerations. Poser CM; Benedikz J; Hibberd PL J Neurol Sci; 1992 Sep; 111(2):143-52. PubMed ID: 1431981 [TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis in time and space--geographic clues to cause. Kurtzke JF J Neurovirol; 2000 May; 6 Suppl 2():S134-40. PubMed ID: 10871801 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics. Kurtzke JF; Hyllested K Acta Neurol Scand; 1987 Nov; 76(5):317-39. PubMed ID: 3501222 [TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Kurtzke JF; Hyllested K Ann Neurol; 1979 Jan; 5(1):6-21. PubMed ID: 371519 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Multiple Sclerosis in Iceland. Elíasdóttir Ó; Kjartansson Ó; Olafsson E Neuroepidemiology; 2018; 51(1-2):50-56. PubMed ID: 29940573 [TBL] [Abstract][Full Text] [Related]
15. Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland. Olafsson E; Benedikz J; Hauser WA Epilepsia; 1999 Jun; 40(6):745-7. PubMed ID: 10368072 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis in a family on the Faroe Islands. Binzer S; Imrell K; Binzer M; Vang S; Rogvi-Hansen B; Hillert J; Stenager E Acta Neurol Scand; 2010 Jan; 121(1):16-9. PubMed ID: 19919645 [TBL] [Abstract][Full Text] [Related]